Follow The Filings

KLRAKailera Therapeutics Inc.

Q2 2026 13F holders among managers we track Latest ownership dossier

Ticker
KLRA
Type
Equity
Class
COMMON STOCK
Total reported value (long equity)
Manager Report date Value Shares